C oronary thrombus has been associated with acute coronary syndromes and disease progression. The rupture of thin cap fibro-atheromas allows the blood to come in contact with the highly thrombogenic contents of the plaque (eg, necrotic core/collagen) favoring the occurrence of most of acute coronary syndromes. 1,2 In addition, invasive imaging studies have shown that coronary thrombosis can also be present in stable coronary artery disease (CAD) and has been associated with plaque progression. 3, 4 Thrombus-containing lesions (TCLs) seems to be associated with an increased risk of distal embolization and no or poor distal flow and low myocardial blush grades after percutaneous coronary intervention. 5,6 However, the prognostic relevance of coronary thrombus as assessed by angiography is still unclear, and the results presented in the literature are disputed. [7] [8] [9] The aim of the present study is to examine the angiographic anatomic characteristics of TCL and their correlations with clinical events (all-cause death, myocardial infarction [MI], and all revascularizations) in the largest-ever pooled all-comer population enrolled in contemporary percutaneous coronary intervention trials.
Implications of Angiographic Coronary Thrombus

Methods
Patient Population
We analyzed patient-level data from 3 all-comer coronary drugeluting stent trials: LEADERS (Limus Eluted From a Durable Versus Erodable Stent Coating) trial, RESOLUTE (Resolute All Comers) trial, and SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery). Detailed individual study design and trial results are available elsewhere. [10] [11] [12] In brief, all studies included patients with obstructive CAD that was amendable to coronary stent implantation ( Table I in the Data Supplement). These trials had an all-comers design, but in the SYNTAX trial, the enrolled patients must had complex (3-vessel or left main) CAD to be enrolled. All studies complied with the Declaration of Helsinki and were approved by the ethical review board in each institution. All patients provided written, informed consent for participation in the individual study. The angiographic images were reviwed by independent core laboratory analysts (Cardialysis, Rotterdam, The Netherlands) who identify the presence or absence of thrombus. Aiming to evaluate the clinical characteristics and prognosis, the patients were divided into 2 groups according to the presence or absence of at least one TCL as assessed by coronary angiography.
Clinical Outcomes
Major adverse cardiac events (MACE) were defined as a composite of all-cause death, MI, and any repeat revascularization. There was a wide variation in the definition of MI among studies. This is because of each study inclusion criteria, variations in study design, and the different periods during which studies were performed. Because all clinical events from each individual trial were adjudicated by independent clinical event committees, no attempt was made to readjudicate MI events in the different trials to compensate for the differences in individual definition of MI. Therefore, all MIs reported in the current study are as per individual study protocol definitions.
WhAT IS KNOWN
• The effect of coronary thrombus on prognosis is disputed, particularly in the era of sophisticated coronary intervention.
WhAT ThE STUDY ADDS
• In a population with a broad spectrum of coronary disease, the presence of intracoronary thrombus was not associated with an increased incidence of adverse outcomes.
• Thombi were most commonly located in proximal coronary locations and at the site of coronary bifurcations. 
Angiographic Assessment
The angiographic assessment was performed by an independent corelab (Cardialysis, Rotterdam, The Netherlands) based on the SYNTAX score concept. The SYNTAX score for each patient was calculated by scoring all coronary lesions with a diameter stenosis ≥50%, in vessels ≥1.5 mm, using the SYNTAX score algorithm, which is described in full elsewhere. 13 All angiographic variables were recorded prospectively by a team of 2 core laboratory analysts.
A bifurcation was classified by a division of a main, parent, branch into 2 daughter branches of at least 1.5 mm diameter according to the Medina classification. 14 The smaller of the 2 daughter branches was designated as the side branch. After the SYNTAX score recommendations, bifurcations were only scored for the following segment junctions: 5/6/11, 6/7/9, 7/8/10, 11/13/12a, 13/14/14a, 3/4/16, and 13/14/15. Coronary thrombus was defined according to the Academic Research Consortium definition as spheric, ovoid, or irregular intraluminal filling defect or lucency surrounded on 3 sides by contrast medium seen just distal or within the coronary stenosis in multiple projections or a visible embolization of intraluminal material downstream. 15 To further evaluate the prognostic effect of thrombus, the summation of segment weighing factors (Table 1 ) used in the SYNTAX score was used if TCLs were present.
Data Analysis
All patients with a calculated SYNTAX score were included in the analysis. Discrete data were summarized as percent (frequencies) and were compared using the chi-squared test. Continuous data were expressed as mean±SD and were compared using Student's t test or Wilcoxon rank-sum test based on their distributions. Survival curves were constructed for time-to-event variables using Kaplan-Meier estimates and compared by the log-rank test. Comparison of events rates between groups were adjusted for confounding factors in a Coxregression model. All variables were stratified according to presence of at least one TCL using a Cox-regression model. The differences were regarded significant when P<0.05 (2-tailed). The Breslow-Day chi-squared test was calculated to test the statistical evidence of heterogeneity across the studies (P<0.1). The chi-squared test and I 2 statistic were calculated to test the statistical evidence of heterogeneity across the studies 16 (Table II and Table 2 depicts patients' baseline demographics. Preprocedural thrombus was present in 257 patients (5.8%) and absent in 4193 (94.2%). Patients with at least one TCL were younger (62.7±10.7 versus 64.6±10.7; P=0.006), more frequently male (80.9% versus 74.6%; P=0.022) and current smokers (51.4% versus 30.5%; P<0.001), less likely to have , and hyperlipidemia (52.9 versus 67.8%; P<0.001). The left ventricular ejection fraction tended to be higher in patients without TCL (56.8±11.9 versus 54.7±11.9; P=0.052). Presence of thrombus at baseline was more frequently related with an acute presentation (P<0.001).
Results
Baseline Characteristics
Angiographic Characteristics
Patients with and without TCL had similar angiographic characteristics (Table 3 ). There were differences for higher prevalence of total occlusions (0.37±0.56 versus 0.27±0.49 total oclusions/patient; P=0.010) and more frequent involvement of the proximal right coronary artery (0.33±0.47 versus 0.27±0.45 lesions/patient; P=0.045) in the thrombus group.
Clinical Outcomes
There was no difference between the groups (Table 4 and Figure 1 ) for any of the studied outcomes ≤3-year follow-up. MACE occurred in 1067 patients (25.4%) in the group without thrombus at baseline and 65 (25.3%) in the group with thrombus (P=0.874). Consistently, all-cause death (P=0.683), MI (P=0.962), and any revascularization (P=0.822) was not significantly different in the 2 groups.
Subgroup Analysis
In the stratified analysis, the occurrence of MACE was homogenously distributed across the clinical and angiographic covariates, with the only exception of clinical presentation ( Figure 2 ). There was a significant interaction between the patients presenting with acute coronary syndrome (hazard ratio 0.881, confidence interval 0.65-1.19) and stable CAD (hazard ratio 1.637, 95% confidence interval 1.04-2.59) with respect to the presence of thrombus at baseline (P=0.028).
A more detailed analysis of the subgroup with stable CAD can be found in Table III in the Data Supplement. The thrombus at baseline was related to a higher rate of MACE (38% versus 26%, P=0.03) mainly because of an increased rate of repeated revascularization (30% versus 18%, P=0.01). However, after adjustment for confounders (ie, age, creatinine 
Anatomic Characteristics of Thrombus Containing Lesions
In the subgroup of patients with TCL (n=257), 261 lesions had angiographic thrombus. As shown in Figure 3 , the presence of TCL occurred preferentially in proximal segments. More specifically, 43.6% of these complex lesions were seen in the first 2 segments of the right coronary artery and 36.8% in the first 2 segments of the left anterior descending coronary artery.
As demonstrated in Figure 4 , TCLs were seen often in coronary bifurcations. The association of thrombus-containing and bifurcation lesions was present in 40.1% of the aforementioned prespecified segments. In the left anterior descending coronary artery, there was appreciable coexistence of thrombus and bifurcation lesions (45.9% of the lesions). On the other hand, the combination thrombus-bifurcation was not frequent in the distal right coronary artery (8.6% of the lesions). 
Clinical Outcomes According to Myocardium at Risk
We divided the subgroup of patients with TCL into tertiles of the sum of segment weighing factors (Table 1) . As shown in Figure 5 , the weighting for myocardium at risk did not produce significant difference in outcomes (MACE, all-cause death, MI or all revascularizations) for patients with TCL. 
Discussion
The findings of our study can be summarized as follows: (1) TCL were seen more often in the proximal segments; (2) there was a considerable coexistence of bifurcation and TCLs; (3) the presence of thrombus at baseline was not related to any additional risk of MACE, even after weighing for myocardium at risk.
Anatomy of Angiographic Coronary Thrombus
Coronary thrombus is mostly formed after rupture of atherosclerotic lesions containing a large necrotic core and a thin fibrous cap. 1, 2 In the present study, we found that thrombus was angiographically detected in the proximal coronary segments and mainly in the right and left anterior descending coronary arteries. Our results are similar to those reported by Wang et al who analyzed coronary angiograms from 208 consecutive patients presented with ST-elevation MI. 17 However, in their methodology, they were evaluating the site of coronary occlusion. Although they used a slightly different coronary segmentation (BARI classification), they also have found that the 2 most proximal segments of right coronary artery and left anterior descending coronary artery were also responsible for the absolute majority (65.4%) of acute coronary occlusion. 17 In the present analysis, a 25-fold larger population was studied and included a population with a broader spectrum of the disease (also stable CAD and NSTEMI) in which the vessel occlusion was not mandatory for diagnosis of thrombus. Importantly, all angiographic assessments were performed by an experienced independent core laboratory, which has proven to have a higher consistency and better prognostic discrimination than investigator-reported angiographic findings. 18 Interestingly, distribution of thin cap fibroatheroma, as assessed by virtual histology intravascular ultrasound (VH-IVUS) and optical coherence tomography, resembles the distribution of thrombus found in the present study; this may indicate that thin cap fibroatheromas are the underlying substrate of coronary thrombus found in this study 19, 20 (Table 5 ). These invasive imaging findings are also in line with previous anatomopathological studies. 2, 4, 21 It has to be highlighted, however, that angiography, because of its limited resolution, is far from being the gold standard tool for coronary thrombus diagnosis. For instance, in the present analysis, there was a low percentage (9.2%) of patients with acute coronary syndromes that were classified as having TCL. Similarly, Goto et al detected angiographic thrombus in only 14.6% of patients in a population of exclusively acute coronary syndromes. 7 Importantly, although Goto et al defined thrombus as "an intraluminal filling defect or an area of contrast staining noted within the target stenosis," 7 we used the definition recommended by the Academic Research Consortium. 15 Another interesting aspect of our findings is the relatively frequent association between thrombus and bifurcation. In the LAD, a bifurcation lesion was present in almost half of the TCL. The most plausible explanations for this association are the following: (1) the most frequent location of thin cap fibroatheromas is in bifurcation 22 and (2) the endothelial shear stress in coronary bifurcations has a particular distribution. In relatively straight segments, the endothelial shear stress is pulsatile and unidirectional. 23 Conversely, in coronary bifurcations, disturbed laminar flow occurs, and pulsatile flow generates low or oscillatory endothelial shear stress. 23 The role of endothelial shear stress in more advanced atherosclerosis was demonstrated 45 years ago 24 and have been reproduced in autopsy-based coronary models, human in vivo studies in arterial models derived from intravascular ultrasound or magnetic resonance, and in vivo animal experiments. 23, 25 
Thrombus and Clinical Events
In the present study, the presence of thrombus did not have any effect on clinical events, even when it was adjusted for the amount of myocardial at risk. Corroborating our findings, Singh et al have shown that the introduction of the coronary stents and the use of more contemporary antiplatelet therapy made the presence of thrombus irrelevant for long-term death and MI. 8 On the other hand, Sianos et al have demonstrated that large thrombus burden is an independent predictor of LAD indicates left anterior descending coronary artery; LCX, left circumflex coronary artery; LM, left main coronary artery; OCT, optical coherence tomography; RCA, right coronary artery; TCFA, thin cap fibroatheroma; and VH, virtual histology intravascular ultrasound. Implications of Angiographic Coronary Thrombus major adverse events (defined as death, repeat MI infarctrelated artery infarct-related artery) in patients treated with drug-eluting stents for STEMI. 9 Additionally, large thrombus burden has been related to larger myocardial damage as detected by contrast-enhanced cardiac magnetic resonance. 26 The aforementioned findings suggest that, for clinical prognostic discrimination, the angiographic thrombus assessment should be no longer classified as a binary variable but as a more detailed thrombotic burden quantification.
Limitations
The present study has all inherent limitations of a post hoc analysis. In addition, the number of stable patients with TCL was limited and may have hindered an accurate risk estimation in this subset. The classification of bifurcation lesions was restricted to those defined by the SYNTAX score, and we could not stablish whether TCL could be associated with smaller side branches. However, the use of the SYNTAX score concepts have demonstrated consistent prognostic effect for percutaneous coronary intervention-treated patients. 12, [27] [28] [29] Information on thrombus aspiration was not available in this study. Nevertheless, the recent Thrombus Aspiration in ST-Elevation MI in Scandinavia (TASTE) trial showed that routine thrombus aspiration exclusively in a context of primary percutaneous coronary intervention did not reduce the rate of death from any cause or the composite of death from any cause, rehospitalization for MI, or stent thrombosis at 1 year. 30 Also, the Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment-Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI (TOTAL) randomly assigned 10 732 patients with STEMI undergoing primary PCI to routine manual thrombectomy versus PCI alone. Manual thrombectomy did not reduce the risk of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or New York Heart Association (NYHA) class IV heart failure within 180 days but was associated with an increased rate of stroke within 30 days. 31 
Conclusions
In this patient-level pooled analysis of 3 contemporary, allcomers stent trials, coronary TCL involved mainly the proximal coronary segments and frequently bifurcations. Angiographic thrombus did not have any effect on 3-year MACE, demonstrating that a more detailed thrombus burden quantification is required to investigate its prognostic implications.
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